Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #12,251 to #12,300.
- Familial hyperreninaemic hypoaldosteronism type 2 (Q100559)
- Haematoma of arm (Q100558)
- Lymphoedematous acne (Q100557)
- Hereditary sensory and autonomic neuropathy with spastic paraplegia (Q100556)
- Hereditary sensory and autonomic neuropathy type IIA (Q100555)
- Hereditary sensory and autonomic neuropathy type IIB (Q100554)
- Nonthermal blister of arm, level unspecified (Q100553)
- Dislocation of upper limb, level unspecified (Q100552)
- Tropical acne (Q100551)
- Familial hyperreninaemic hypoaldosteronism type 1 (Q100550)
- Nonvenomous insect bite of arm, level unspecified (Q100549)
- Abrasion of arm, level unspecified (Q100548)
- Autoimmune encephalitis, neural autoantibody positive (Q100547)
- Cervical stricture in pregnancy or childbirth (Q100546)
- Superficial foreign body in arm, level unspecified (Q100545)
- Haematoma of upper extremity artery (Q100544)
- Hereditary sensory and autonomic neuropathy with deafness or global delay (Q100543)
- Sprain of upper limb, level unspecified (Q100542)
- Cervical stenosis in pregnancy or childbirth (Q100541)
- Hereditary sensory and autonomic neuropathy type IIC (Q100540)
- X-linked hereditary sensory and autonomic neuropathy with deafness (Q100539)
- Assault by exposure to or harmful effects of camphor (Q100538)
- Contusion of arm, level unspecified (Q100537)
- Assault by exposure to or harmful effects of ophthalmological drugs or preparations (Q100536)
- Assault by exposure to or harmful effects of other dental drugs, topically applied (Q100535)
- Assault by exposure to or harmful effects of emollients, demulcents or protectants (Q100534)
- Assault by exposure to or harmful effects of antipruritics (Q100533)
- Assault by exposure to or harmful effects of fluoride preparations (Q100532)
- Assault by exposure to or harmful effects of iodine, antiseptic (Q100531)
- Assault by exposure to or harmful effects of podophyllin (Q100530)
- Assault by exposure to or harmful effects of topical corticosteroid preparations (Q100529)
- Assault by exposure to or harmful effects of otorhinolaryngological drugs or preparations (Q100528)
- Assault by exposure to or harmful effects of antidiarrhoeal drugs (Q100527)
- Assault by exposure to or harmful effects of emetics (Q100526)
- Assault by exposure to or harmful effects of keratolytics, keratoplastics, or other hair treatment drugs or preparations (Q100525)
- Assault by exposure to or harmful effects of other local antifungal, anti-infective or anti-inflammatory drugs (Q100524)
- Assault by exposure to or harmful effects of other local astringents or local detergents (Q100523)
- Assault by exposure to or harmful effects of methyl salicylate (Q100522)
- Assault by exposure to or harmful effects of silver nitrate (Q100521)
- Assault by exposure to or harmful effects of digestants (Q100520)
- Assault by exposure to or harmful effects of other laxatives (Q100519)
- Assault by exposure to or harmful effects of loop diuretics (Q100518)
- Assault by exposure to or harmful effects of iron or its compounds (Q100517)
- Assault by exposure to or harmful effects of other fibrinolysis-affecting drugs (Q100516)
- Assault by exposure to or harmful effects of other antacids or anti-gastric-secretion drugs (Q100515)
- Assault by exposure to or harmful effects of saline or osmotic laxatives (Q100514)
- Assault by exposure to or harmful effects of plasma substitutes (Q100513)
- Assault by exposure to or harmful effects of antithrombotic drugs (Q100512)
- Assault by exposure to or harmful effects of thrombolytic drug (Q100511)
- Assault by exposure to or harmful effects of benzothiadiazine derivatives (Q100510)
